-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 25

 

NOTIFICATION OF REMOVAL FROM LISTING AND/OR

REGISTRATION UNDER SECTION 12(b) OF THE

SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-33537

 

China Shenghuo Pharmaceutical Holdings, Inc. ; NYSE Amex LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

 

No. 2 Jing You Road, Kunming National Economy & Technology Developing District, People’s Republic of China 650217

(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)

 

Common Shares, $0.0001 par value

(Description of class of securities)

 

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

 

o

17CFR240.12d2-2(a)(1)

 

o

17CFR240.12d2-2(a)(2)

 

o

17CFR240.12d2-2(a)(3)

 

o

17CFR240.12d2-2(a)(4)

 

o Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

 

x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, China Shenghuo Pharmaceutical Holdings, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

 

April 30, 2012				By:		/s/ Feng Lan			Chief Executive Officer and President
Date						Name: Feng Lan			Title

 

 

 

^1. Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

 

SEC 1654 (03-06) 

Persons who respond to the collection of information contained
in this form are not required to respond unless the form displays
a currently valid OMB control number.